Lombardi, G., de Salvo, G., Rudà, R., Franceschi, E., Eoli, M., Faedi, M., Pace, A., Lolli, I., Rizzato, S., Germano, D., Pasqualetti, F., Farina, M., Magni, G., Bellu, L., Caccese, M., Pambuku, A., Bergo, E., Indraccolo, S., Gardiman, M., Soffietti, R., & Zagonel, V. (n.d.). oS2.3 Updated results of REGOMA: A randomized, multicenter, controlled open-label phase II clinical trial evaluating regorafenib in relapsed glioblastoma <GBM> patients <PTS>. Neuro-oncology, 20, iii219. http://access.bl.uk/ark:/81055/vdc_100095497514.0x000015